Freestone Grove Partners’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-838,057
Closed -$37.1M 1037
2025
Q4
$37.1M Buy
838,057
+544,599
+186% +$30.6M 0.27% 121
2025
Q3
$21.5M Sell
293,458
-292,078
-50% -$19M 0.16% 196
2025
Q2
$35.9M Buy
+585,536
New +$32.7M 0.27% 135
2025
Q1
Sell
-170,875
Closed -$9.12M 640
2024
Q4
$9.12M Buy
+170,875
New +$8.37M 0.11% 202

Other funds holding DOCS

Freestone Grove Partners's DOCS Position: Q1 2026 in Review

Freestone Grove Partners sold out of Doximity (DOCS) in Q1 2026, closing a stake of 838,057 shares — an estimated $37.1M sold.

Freestone Grove Partners first reported a position in DOCS in Q4 2024 and held it in 4 quarters. The position peaked at $37.1M in Q4 2025. 423 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Freestone Grove Partners reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 838,057 Doximity shares in Q1 2026, an estimated $37.1M.
  • Freestone Grove Partners first reported a position in Doximity in Q4 2024 and held it in 4 quarters.
  • Freestone Grove Partners's Doximity position peaked at $37.1M in Q4 2025.
  • 423 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.